CALLEJA , Anne

Introduction: Therapy related myelodysplastic syndrome and acute myeloid leukemia (t-MDS/AML) are defined as complications of previous cytotoxic therapy. Azacitidine (AZA), a hypomethylating agent, has showed activity in t-MDS/AML.Objectives: We evaluated the clonal dynamics of AZA treated t-MDS/AML. Methods: We collected bone marrow samples,...

International audience